Efficacy of combined anti-TNF-alpha and surgical therapy in perianal and enterocutaneous fistulizing Crohn’s disease – clinical observations from a tertiary Eastern European center

Long-term Outcome of Perianal Fistulizing Crohn's Disease Treated With Infliximab

(2013) Guillaume Bouguen et al.   Clinical Gastroenterology and Hepatology

Combined modality treatment for complex fistulating perianal Crohn’s disease

(2012) R. Antakia et al.   Colorectal Disease

Specific quality of life factors in patients with inflammatory bowel disease

(2012) Beáta Nagy et al.   ORVOSI HETILAP

Quality of Life in Perianal Crohnʼs Disease: What Do Patients Consider Important?

(2011) Srihari Mahadev et al.   DISEASES OF THE COLON & RECTUM

The CHOICE trial: adalimumab demonstrates safety, fistula healing, improved quality of life and increased work productivity in patients with Crohn’s disease who failed prior infliximab therapy

(2010) S. Lichtiger et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Combined approach with infliximab, surgery, and methotrexate in severe fistulizing anoperineal Crohnʼs disease: Results from a prospective study

(2010) Pauline Roumeguère et al.   INFLAMMATORY BOWEL DISEASES

Is the disease course predictable in inflammatory bowel diseases?

(2010) Peter Laszlo Lakatos   WORLD JOURNAL OF GASTROENTEROLOGY

Clinical trial: benefits and risks of immunomodulators and maintenance infliximab for IBD-subgroup analyses across four randomized trials

(2009) G. R. LICHTENSTEIN et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

The Natural History of Adult Crohn's Disease in Population-Based Cohorts

(2009) Laurent Peyrin-Biroulet et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Long-term outcome of treatment with infliximab in 614 patients with Crohn's disease: results from a single-centre cohort

(2008) F Schnitzler et al.   GUT